SCHIZOPHRENIFORM DISORDER
Clinical trials for SCHIZOPHRENIFORM DISORDER explained in plain language.
Never miss a new study
Get alerted when new SCHIZOPHRENIFORM DISORDER trials appear
Sign up with your email to follow new studies for SCHIZOPHRENIFORM DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could lowering antipsychotic doses help some schizophrenia patients function better?
Disease control Not yet recruitingThis study tests whether carefully reducing antipsychotic medication in stable schizophrenia patients can improve their daily functioning compared to staying on the same dose. Researchers will group 288 adults aged 18–60 by their specific psychosis type and randomly assign them t…
Matched conditions: SCHIZOPHRENIFORM DISORDER
Phase: PHASE2 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Optical illusions could train social skills in psychosis
Symptom relief Not yet recruitingThis study tests whether a 45-minute session of viewing visual illusions with a partner can improve social cognition in people with psychotic disorders. Social cognition is the ability to understand what others think or feel. Sixty participants will be guided through illusion box…
Matched conditions: SCHIZOPHRENIFORM DISORDER
Phase: NA • Sponsor: Hôpital le Vinatier • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New AR game app aims to spark motivation in schizophrenia patients
Symptom relief Not yet recruitingThis study tests a smartphone app called NST-SPARK that uses augmented reality games to help people with schizophrenia who struggle with low motivation, lack of pleasure, and social withdrawal. About 30 adults with these symptoms will use the app for 12 weeks. The goal is to see …
Matched conditions: SCHIZOPHRENIFORM DISORDER
Phase: NA • Sponsor: North Shore Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
CBD shows promise for Hard-to-Treat psychosis in major new trial
Symptom relief Not yet recruitingThis study tests whether adding cannabidiol (CBD) to standard antipsychotic medication can improve symptoms in people experiencing their first episode of psychosis who haven't responded well to initial treatment. About 250 participants aged 16-40 will receive either CBD or a plac…
Matched conditions: SCHIZOPHRENIFORM DISORDER
Phase: PHASE3 • Sponsor: University of Oxford • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Brain games and drugs: a new hope for psychosis?
Knowledge-focused Not yet recruitingThis study looks at whether a single dose of modafinil or D-serine can improve decision-making and thinking in people who have had psychosis for less than five years. Twenty-four participants will play computer brain games and have brain scans before and after taking the drugs. T…
Matched conditions: SCHIZOPHRENIFORM DISORDER
Phase: PHASE3 • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Brain scans reveal how new schizophrenia drug cobenfy works
Knowledge-focused Not yet recruitingThis study will use brain scans (PET/MRI) to see how the drug Cobenfy affects dopamine in the brains of 12 people with schizophrenia. Participants will take one of three doses of Cobenfy for 5 weeks and get a brain scan before and after treatment. The goal is to understand how th…
Matched conditions: SCHIZOPHRENIFORM DISORDER
Phase: PHASE1, PHASE2 • Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Teaching patients about their pills: a simple fix for better mental health?
Knowledge-focused Not yet recruitingThis study looks at whether teaching people in the hospital about their psychiatric medications helps them stick to their treatment and handle side effects. Researchers will work with 64 adults who have serious mental illnesses like schizophrenia or bipolar disorder. The goal is …
Matched conditions: SCHIZOPHRENIFORM DISORDER
Phase: NA • Sponsor: Cumhuriyet University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Could a nasal insulin spray rewire the brain in psychosis?
Knowledge-focused Not yet recruitingThis study investigates how insulin delivered through the nose changes dopamine signaling and energy use in the brains of people with first-episode psychosis. Researchers will compare brain scans and chemical levels in 46 participants (patients and healthy volunteers) after recei…
Matched conditions: SCHIZOPHRENIFORM DISORDER
Phase: NA • Sponsor: Medical University of Vienna • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC